Antibiotice will have an Inova a+ research and development center and the new technologies can help discover drugs fast and in the testing and validation process of a new molecule.
IBM Research Vice President Jason Silbergleit discussed with Antibiotice CEO Ioan Nani, as well as with Antibiotice’s head of R&D Gianina Macovei and of Strategic Planning and Portfolio Management Stefania Alexandru and a team of young research and IT specialists.
“Strategic partnerships with global leaders like IBM are essential to the future of Antibiotice Iasi (…) The opportunity to work with IBM will strengthen our capability to develop advanced therapeutical solutions and will contribute to creating a sustainable innovation ecosystem in a viable partnership between the industry, the academic community and the technology sector,” Antibiotice CEO Ioan Nani said.
In 2024, Antibiotice Iasi signed a partnership with IBM to implement the digital SAP S/4HANA solution, the most advanced enterprise resource planning software.
(English version by Loredana Fratila-Cristescu)